Oscar Health (NYSE: OSCR ) released its Q2 earnings last week, which was very much in line with the preliminary results it issued. Since then, Oscar's price has rebounded pretty well from the recent low, but stillMy investment philosophy centers on three primary areas of focus. First, I specialize in analyzing high-quality growth companies with sustainable competitive advantages and expanding market opportunities, particularly enjoying uncovering emerging growth stories before they gain widespread attention ...